Lang Sheng Investment Group Co. Ltd.
Venture capitalShanghai · Pre-Seed–Series B · 7 people tracked
Investment thesis
Lang Sheng Investment specializes in the large-health/medical sector in China, backing early-stage medical and biotech companies. It frequently serves as the exclusive or lead investor in Series A or angel rounds of medical unicorns, applying a long-term value-investing approach to support companies through economic cycles toward becoming global leaders. Its portfolio spans innovative drugs, medical devices, medical imaging, cancer early-screening, and health management technologies. The firm emphasizes using entrepreneurial spirit to turn technology into productive force, and has cultivated multiple industry-leading enterprises, several of which have gone public on China's STAR Market and the Hong Kong Stock Exchange.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
Investments · 16 tracked
founders shown can be your intro pathBrain-machine interface technology company.
Healthcare/biotech company in Lang Sheng's portfolio.
Medical technology company (Ankon), a portfolio medical unicorn.
Clinical-stage biotech developing innovative cancer immunotherapies around the CD47 target; listed on HKEX (01541) in Sept 2023.
Clinical-stage biotech developing innovative tumor immunotherapies around the CD47 target; listed on HKEX (01541) in 2023.
Pharmaceutical company; listed on the STAR Market in April 2022.
Pharmaceutical company listed on the STAR Market in April 2022.
Medical imaging company developing swept-source OCT and OCTA systems, founded in Silicon Valley (SVision Research).
High-tech company developing advanced medical imaging systems, including swept-source OCT and OCTA.
High-tech company developing advanced medical imaging systems, focused on swept-source OCT and OCTA.
Portfolio company of Lang Sheng Investment.
CAE industrial software company listed on the STAR Market (688507) in April 2023.
CAE industrial software company listed on the STAR Market (688507) in April 2023.
Medical device company; first to receive approval for irreversible electroporation Class III devices for prostate conditions.
Frequently asked questions
- How many investments has Lang Sheng Investment Group Co. Ltd. made?
- Lang Sheng Investment Group Co. Ltd. has 16 tracked investments.
- What stage does Lang Sheng Investment Group Co. Ltd. invest at?
- Lang Sheng Investment Group Co. Ltd. invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does Lang Sheng Investment Group Co. Ltd. focus on?
- Lang Sheng Investment Group Co. Ltd. focuses on Biotech, Consumer, Data & Infrastructure, Digital Health, Enterprise Software, Healthtech, Medical Devices, SaaS, Wellness & Fitness.
- Where is Lang Sheng Investment Group Co. Ltd. located?
- Lang Sheng Investment Group Co. Ltd. is headquartered in Shanghai, CN.
- Does Lang Sheng Investment Group Co. Ltd. lead rounds?
- Yes, Lang Sheng Investment Group Co. Ltd. leads investment rounds.
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.
WRF Capital invests in venture-backed companies and operates as the investment arm of the Washington Research Foundation, established in 1981. The firm focuses on commercializing technology emerging from Washington state research institutions and universities.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.